Surfing the NASH Tsunami

The Day After TLMdX 2020 Wrapping Up with The View from Across the Atlantic - Ep 38

November 19, 2020 HEP Dynamics LLC Season 1 Episode 38
Surfing the NASH Tsunami
The Day After TLMdX 2020 Wrapping Up with The View from Across the Atlantic - Ep 38
Chapters
Surfing the NASH Tsunami
The Day After TLMdX 2020 Wrapping Up with The View from Across the Atlantic - Ep 38
Nov 19, 2020 Season 1 Episode 38
HEP Dynamics LLC

Prof.  Vlad Ratziu, MD, and Prof. Dr. Jörn M. Schattenberg join the Surfers to wrap up our conversation about this year's AASLD meeting.

Prof. Dr. Jörn M. Schattenberg erg and Prof.  Vlad Ratziu, MD join the Surfers for our wrap-up episode for TLMdX 2020. Joern focuses on a diabetes poster demonstrating the path of drug efficacy over a three-year period, while Vlad focuses on the successful Phase 2 trial of the pan-PPAR lanifibranor. The group also asks why placebo response varies so much between studies and whether the ratio of F2:F3 patients may be a factor. Finally, the Surfers focuses on what they consider the biggest lessons emerging from the meeting.

Show Notes

Prof.  Vlad Ratziu, MD, and Prof. Dr. Jörn M. Schattenberg join the Surfers to wrap up our conversation about this year's AASLD meeting.

Prof. Dr. Jörn M. Schattenberg erg and Prof.  Vlad Ratziu, MD join the Surfers for our wrap-up episode for TLMdX 2020. Joern focuses on a diabetes poster demonstrating the path of drug efficacy over a three-year period, while Vlad focuses on the successful Phase 2 trial of the pan-PPAR lanifibranor. The group also asks why placebo response varies so much between studies and whether the ratio of F2:F3 patients may be a factor. Finally, the Surfers focuses on what they consider the biggest lessons emerging from the meeting.